European Healthcare Expenditure on Retailers of Medical Goods by NPISH Financing Schemes by Country

In 2023, Iceland had the highest healthcare expenditure on retailers of medical goods by NPISH financing schemes among the listed countries, standing at 0.84% of total current health expenditure. The United Kingdom followed with 0.21%, while Estonia and Latvia recorded 0.15% and 0.09% respectively. Poland was the lowest with 0.04%. Notably, Latvia experienced a significant year-on-year increase of 22.47% in 2023, demonstrating remarkable growth dynamics. In contrast, Estonia and Poland saw no variation, and Iceland showed a small increase of 0.73% over the same period.

Future trends to watch in European Healthcare Expenditure by NPISH financing schemes include:

• The potential increase in NPISH funding for medical goods as nations seek alternative financing mechanisms for healthcare.
• The impact of economic factors and policy changes, especially in countries with currently low NPISH expenditure.
• The role of technology and innovation in driving efficiencies and potentially altering budgeting priorities towards NPISH-funded initiatives.